NYSEAMERICAN : CVM
CEL-SCI Corporation — Financial statements
Healthcare · Biotechnology · United States
Last price 1.45 USD (Oct 30, 2026, 9:39 AM EDT) · Market cap 25.50M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year October - September; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cost of Revenue | 14.80M | 15.89M | 18.16M | 22.47M | 25.36M | 23.11M |
| Gross Profit | -14.80M | -15.89M | -18.16M | -22.47M | -25.36M | -23.11M |
| Selling, General & Admin | 7.49M | 8.92M | 8.19M | 9.00M | 10.71M | 13.09M |
| Operating Expenses | 7.49M | 8.92M | 8.19M | 9.00M | 10.71M | 13.09M |
| Operating Income | -22.29M | -24.81M | -26.35M | -31.48M | -36.06M | -36.19M |
| Interest Expense | -444.02K | -648.94K | -745.67K | -675.42K | -1.08M | -1.13M |
| Other Non Operating Income (Expenses) | 47.62K | 47.62K | -481.77K | -214.37K | -455.18K | -1.08M |
| EBT Excluding Unusual Items | -22.68M | -25.41M | -27.58M | -32.37M | -37.60M | -38.40M |
| Gain (Loss) on Sale of Investments | 1.69M | |||||
| Asset Writedown | -21.80K | -30.79K | ||||
| Pretax Income | -22.70M | -25.41M | -27.58M | -32.37M | -37.63M | -36.71M |
| Net Income | -22.70M | -25.41M | -27.58M | -32.37M | -37.63M | -36.71M |
| Net Income to Common | -22.70M | -25.41M | -27.58M | -32.37M | -37.63M | -36.71M |
| Shares Outstanding (Basic) | 8.84M | 4.06M | 1.80M | 1.48M | 1.44M | 1.36M |
| Shares Outstanding (Diluted) | 8.84M | 4.06M | 1.80M | 1.48M | 1.44M | 1.36M |
| EPS (Basic) | -2.57 | -6.27 | -15.31 | -21.83 | -26.17 | -27.09 |
| EPS (Diluted) | -2.57 | -6.27 | -15.31 | -21.83 | -26.17 | -27.87 |
| Free Cash Flow | -16.75M | -17.16M | -18.91M | -23.21M | -18.88M | -27.80M |
| Free Cash Flow Per Share | -1.90 | -4.23 | -10.49 | -15.66 | -13.13 | -20.50 |
| EBITDA | -20.26M | -22.72M | -24.18M | -29.32M | -34.03M | -33.96M |
| D&A For EBITDA | 2.03M | 2.09M | 2.17M | 2.16M | 2.03M | 2.23M |
| EBIT | -22.29M | -24.81M | -26.35M | -31.48M | -36.06M | -36.19M |
Balance sheet
Fiscal year October - September; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 6.53M | 10.95M | 4.74M | 4.15M | 22.67M | 36.06M |
| Short-Term Investments | 7.80K | 7.08K | 3.50K | 4.25K | 6.15M | |
| Cash & Short-Term Investments | 6.54M | 10.96M | 4.74M | 4.15M | 22.67M | 42.21M |
| Other Receivables | 54.92K | |||||
| Receivables | 54.92K | |||||
| Inventory | 266.76K | 303.28K | 1.02M | 2.25M | 2.00M | 2.01M |
| Prepaid Expenses | 702.02K | 332.30K | 294.10K | 520.37K | 762.06K | 998.48K |
| Total Current Assets | 7.50M | 11.60M | 6.06M | 6.92M | 25.44M | 45.27M |
| Property, Plant & Equipment | 10.22M | 12.90M | 16.98M | 21.02M | 24.71M | 28.41M |
| Other Intangible Assets | 69.69K | 119.86K | 165.49K | 197.70K | 212.20K | 275.87K |
| Other Long-Term Assets | 3.56M | 3.54M | 3.79M | 2.39M | 164.30K | 1.91M |
| Total Assets | 21.36M | 28.16M | 26.99M | 30.53M | 50.52M | 75.87M |
| Accounts Payable | 1.02M | 1.06M | 1.45M | 2.01M | 1.62M | 1.68M |
| Accrued Expenses | 1.35M | 1.63M | 929.35K | 1.61M | 1.31M | 1.13M |
| Current Portion of Leases | 2.70M | 2.44M | 2.24M | 1.97M | 1.73M | 698.66K |
| Other Current Liabilities | 437.38K | |||||
| Total Current Liabilities | 5.08M | 5.13M | 4.62M | 5.59M | 4.66M | 3.94M |
| Long-Term Leases | 5.19M | 6.94M | 9.38M | 11.60M | 13.57M | 15.27M |
| Other Long-Term Liabilities | 125.00K | 125.00K | 125.00K | 125.00K | 125.00K | 125.00K |
| Total Liabilities | 10.40M | 12.20M | 14.12M | 17.31M | 18.36M | 19.34M |
| Common Stock | 173.08K | 80.16K | 21.27K | 474.22K | 434.48K | 432.07K |
| Additional Paid-In Capital | 566.81M | 555.30M | 526.86M | 499.83M | 486.63M | 474.30M |
| Retained Earnings | -556.03M | -539.42M | -514.01M | -487.09M | -454.90M | -418.20M |
| Shareholders' Equity | 10.96M | 15.96M | 12.87M | 13.21M | 32.16M | 56.53M |
| Total Liabilities & Equity | 21.36M | 28.16M | 26.99M | 30.53M | 50.52M | 75.87M |
| Total Debt | 7.90M | 9.38M | 11.62M | 13.57M | 15.30M | 15.97M |
| Net Cash (Debt) | -1.36M | 1.58M | -6.88M | -9.42M | 7.37M | 26.24M |
| Net Cash Per Share | -0.15 | 0.39 | -3.82 | -6.36 | 5.12 | 19.35 |
| Filing Date Shares Outstanding | 17.59M | 8.41M | 2.47M | 1.67M | 1.46M | 1.44M |
| Total Common Shares Outstanding | 17.59M | 8.02M | 2.13M | 1.58M | 1.45M | 1.44M |
| Working Capital | 2.42M | 6.47M | 1.44M | 1.33M | 20.77M | 41.33M |
| Book Value Per Share | 0.62 | 1.99 | 6.05 | 8.36 | 22.21 | 39.26 |
| Tangible Book Value | 10.89M | 15.84M | 12.70M | 13.02M | 31.95M | 56.26M |
| Tangible Book Value Per Share | 0.62 | 1.98 | 5.97 | 8.24 | 22.06 | 39.07 |
| Machinery | 4.21M | 4.27M | 4.21M | 4.19M | 4.31M | |
| Leasehold Improvements | 13.92M | 13.92M | 13.92M | 13.54M | 13.47M |
Cash flow statement
Fiscal year October - September; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -22.70M | -25.41M | -27.58M | -32.37M | -37.63M | -36.71M |
| Depreciation & Amortization | 3.83M | 3.89M | 3.97M | 3.96M | 3.83M | 2.23M |
| Asset Writedown & Restructuring Costs | 519.86K | 369.16K | 30.79K | |||
| Loss (Gain) From Sale of Investments | -615.00 | -5.62K | ||||
| Stock-Based Compensation | 2.46M | 2.88M | 5.35M | 7.15M | 12.38M | 15.11M |
| Other Operating Activities | 30.76K | -5.81K | 664.33K | 186.84K | 671.72K | 1.10M |
| Change in Inventory | 360.73K | 973.66K | -172.61K | -156.73K | -159.43K | -1.19M |
| Change in Accounts Payable | -486.47K | -442.71K | -460.58K | 257.85K | 374.89K | 445.98K |
| Change in Other Net Operating Assets | -756.76K | 627.88K | -579.01K | -1.88M | 2.27M | 225.64K |
| Operating Cash Flow | -16.75M | -17.12M | -18.81M | -22.85M | -18.24M | -18.79M |
| Capital Expenditures | -5.16K | -38.11K | -94.88K | -361.89K | -637.89K | -9.02M |
| Sale (Purchase) of Intangibles | -13.21K | -10.37K | -22.74K | -22.64K | ||
| Investment in Securities | 6.15M | -6.15M | ||||
| Investing Cash Flow | -5.16K | -38.11K | -108.09K | -372.26K | 5.49M | -15.18M |
| Short-Term Debt Issued | 350.00K | 450.00K | ||||
| Long-Term Debt Issued | 786.45K | 1.61M | ||||
| Total Debt Issued | 350.00K | 450.00K | 786.45K | 1.61M | ||
| Short-Term Debt Repaid | -350.00K | -450.00K | ||||
| Long-Term Debt Repaid | -2.01M | -1.77M | -1.56M | -1.39M | -1.08M | |
| Total Debt Repaid | -2.21M | -2.36M | -2.22M | -1.56M | -1.39M | -1.08M |
| Net Debt Issued (Repaid) | -2.21M | -2.01M | -1.77M | -1.56M | -600.04K | 534.15K |
| Issuance of Common Stock | 26.38M | 28.51M | 23.66M | 7.00M | 131.06K | 54.31M |
| Other Financing Activities | -2.69M | -3.13M | -2.37M | -744.91K | -169.44K | -325.03K |
| Financing Cash Flow | 21.49M | 23.37M | 19.51M | 4.69M | -638.43K | 54.52M |
| Net Cash Flow | 4.73M | 6.22M | 592.44K | -18.53M | -13.39M | 20.55M |
| Free Cash Flow | -16.75M | -17.16M | -18.91M | -23.21M | -18.88M | -27.80M |
| Free Cash Flow Per Share | -1.90 | -4.23 | -10.49 | -15.66 | -13.13 | -20.50 |
| Levered Free Cash Flow | -8.91M | -8.19M | -7.51M | -8.68M | -7.68M | -15.85M |
| Unlevered Free Cash Flow | -8.64M | -7.78M | -7.05M | -8.26M | -7.01M | -15.14M |
| Cash Interest Paid | 633.87K | 768.47K | 923.81K | 1.06M | 1.16M | 1.17M |
| Change in Working Capital | -882.50K | 1.16M | -1.21M | -1.78M | 2.48M | -514.91K |
Ratios
Fiscal year October - September; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 24.27M | 73.54M | 65.18M | 59.08M | 134.01M | 472.88M |
| Enterprise Value | 25.64M | 81.70M | 76.88M | 67.94M | 121.63M | 441.02M |
| Last Close Price | 1.38 | 9.20 | 31.80 | 37.50 | 92.71 | 329.73 |
| Forward PE | 113.00 | 113.00 | 113.00 | 106.00 | 66.78 | |
| PB Ratio | 2.22 | 4.61 | 5.07 | 4.47 | 4.17 | 8.36 |
| P/TBV Ratio | 2.23 | 4.64 | 5.13 | 4.54 | 4.19 | 8.40 |
| Debt / Equity Ratio | 0.72 | 0.59 | 0.90 | 1.03 | 0.48 | 0.28 |
| Net Debt / Equity Ratio | 0.12 | -0.10 | 0.54 | 0.71 | -0.23 | -0.46 |
| Net Debt / EBITDA Ratio | -0.07 | 0.07 | -0.28 | -0.32 | 0.22 | 0.77 |
| Net Debt / FCF Ratio | -0.08 | 0.09 | -0.36 | -0.41 | 0.39 | 0.94 |
| Inventory Turnover | 37.71 | 24.01 | 11.12 | 10.57 | 12.65 | 16.35 |
| Quick Ratio | 1.29 | 2.14 | 1.03 | 0.74 | 4.86 | 10.74 |
| Current Ratio | 1.48 | 2.26 | 1.31 | 1.24 | 5.45 | 11.50 |
| Return on Equity (ROE) | -252.53% | -176.32% | -211.49% | -142.65% | -84.85% | -96.28% |
| Return on Assets (ROA) | -66.82% | -56.23% | -57.27% | -48.54% | -35.66% | -38.87% |
| Return on Capital Employed (ROCE) | -136.90% | -107.80% | -117.80% | -126.20% | -78.60% | -50.30% |
| Earnings Yield | -186.15% | -34.55% | -42.31% | -54.79% | -28.08% | -7.76% |
| FCF Yield | -69.01% | -23.33% | -29.00% | -39.29% | -14.09% | -5.88% |
| Buyback Yield / Dilution | -215.73% | -125.13% | -21.52% | -3.08% | -6.03% | -10.71% |